BPC-157 is a gastric pentadecapeptide studied in preclinical models of tissue integrity, angiogenesis, and NO signaling.
Pre-loaded with a typical BPC-157 vial. Change any value to match what you actually have.
What published research and laboratory protocols actually document for BPC-157. Where a compound has no single microgram figure, we say so rather than inventing one.
| Reported amount | Frequency | Route | Where this figure comes from |
|---|---|---|---|
| 0.01 mcg – 10 mcg | varies by animal model | intraperitoneal, oral, topical, or local in animal studies | Preclinical BPC-157 animal studies frequently report ng/kg to mcg/kg exposure bands Values are per kg in many papers; do not convert directly into human dosing. |
| 10 mcg | model-dependent | animal-study routes vary | Rodent injury and gastrointestinal models often cite 10 mcg/kg as an experimental exposure Preclinical reference only. |
People searching this page also look for: bpc 157 peptide dosage chart, bpc 157 peptide dosage, bpc-157 peptide dosage, bpc 157 peptide dosage by weight, bpc 157 peptide dosage calculator, bpc-157 peptide benefits dosage side effects, bpc-157 peptide dosage chart, peptide bpc 157 dosage.
BPC-157 is a 15-amino-acid peptide derived from a body-protection-compound sequence associated with gastric juice research. Most published work is preclinical, with animal models examining wound repair, tendon and ligament injury, gastrointestinal integrity, vascular responses, and nitric-oxide-system interactions. Human evidence is much thinner than internet discussion suggests.
Because the literature is dominated by rodent and other animal models, BPC-157 education needs careful framing. Research-grade BPC-157 is Research Use Only and is not an approved drug product. Reported ranges below reflect published animal-study exposure styles and should not be converted into human protocols.
BPC-157 is studied for interactions with cytoprotective pathways, angiogenesis-related signaling, nitric oxide balance, and tissue-response networks. Preclinical papers describe effects on vascular integrity, growth-factor expression, inflammatory responses, and gastrointestinal mucosal resilience. The exact receptor-level mechanism is not settled, and much of the evidence comes from model-specific injury systems. That uncertainty is why species, route, and endpoint matter so much in BPC-157 interpretation.
wound healing models · tendon and ligament research · gastrointestinal integrity · angiogenesis signaling · nitric oxide pathways
BPC-157 is studied mainly by preclinical pharmacology groups, gastrointestinal researchers, sports-medicine reviewers, and analytical laboratories. Human clinical researchers generally treat the evidence base as preliminary and not interchangeable with approved peptide therapeutics.
Lyophilized BPC-157 is commonly stored frozen or refrigerated, dry, and protected from light; reconstituted research solutions are usually refrigerated and handled aseptically.
BPC-157 is commonly paired in online discussion with TB-500, GHK-Cu, or recovery-focused compounds, but those combinations outrun the human evidence. Research protocols should isolate injury model, route, and endpoint before combining peptides, especially when the base evidence is preclinical.
The questions people actually search for, answered plainly.
Published BPC-157 research is mostly animal work, often reported as ng/kg or mcg/kg. Those values are reference information and are not human dosing instructions.
Common research examples use 1-3 mL for 5-10 mg vials. Reconstitution volume changes concentration only.
Daily BPC-157 schedules in online charts are not the same as published study protocols. A literature-based answer must specify species, route, and model.
A responsible chart should separate animal-study mcg/kg values from vial concentration math and should avoid presenting either as a recommendation.
Preclinical studies often assess endpoints over days to weeks depending on the injury model. There is no universal timeline.
A clinically useful human half-life has not been established. Stability and exposure are discussed mostly in research-model terms.
It can be studied with other compounds, but stacking makes attribution difficult and is not supported as a human-use protocol.
Primary literature on BPC-157. Open access where available.
Every citation above was programmatically checked against the NCBI PubMed database. Titles shown are the official indexed titles, not paraphrases.
Our support assistant walks through reconstitution, syringe units, storage, and how to read a Certificate of Analysis. Free, no account.
Read the guides